Drug Type Small molecule drug |
Synonyms AUR 105, AUR105 |
Target |
Mechanism CD47 inhibitors(Cluster of differentiation 47 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hodgkin's Lymphoma | Phase 1 | IN | 30 Nov 2022 | |
Non-Hodgkin Lymphoma | Phase 1 | IN | 30 Nov 2022 | |
Solid tumor | Phase 1 | IN | 30 Nov 2022 |